Iron Sucrose Dosing for 1200 mg Iron Deficit
For an iron deficit of 1200 mg, administer 6 doses of 200 mg iron sucrose given over 2-5 minutes as slow IV injection, or alternatively 12 doses of 100 mg if the patient is on hemodialysis.
Dosing Algorithm Based on Patient Population
For Hemodialysis Patients (HDD-CKD)
- Standard regimen: 100 mg per hemodialysis session 1
- Total doses needed: 12 doses to deliver 1200 mg
- Administration: Undiluted slow IV injection over 2-5 minutes, or diluted in maximum 100 mL 0.9% NaCl over 15 minutes 1
- Timing: Administer early during dialysis session (generally within first hour) 1
For Non-Dialysis or Peritoneal Dialysis Patients
- Preferred regimen: 200 mg per dose 1
- Total doses needed: 6 doses to deliver 1200 mg
- Administration: Undiluted slow IV injection over 2-5 minutes or diluted in maximum 100 mL 0.9% NaCl over 15 minutes 1
- Schedule: Given on different occasions over 14 days 1
Maximum Safe Single Dose Considerations
Iron sucrose has a maximum recommended single dose of 200 mg 2. While the FDA label permits 200 mg doses 1, research demonstrates that:
- 300 mg doses over 2 hours are safe with no adverse reactions in 189 patients 3
- 400-500 mg doses carry unacceptably high adverse event rates (hypotension, nausea, lower back pain) and should be avoided 3
- Individual doses above 300 mg are not recommended 4
Clinical Rationale
The guidelines consistently emphasize that iron sucrose can be given in doses of 100 mg or less as the standard approach 2, though 200 mg doses are FDA-approved and widely used 1. The 200 mg dosing reduces the number of required visits from 12 to 6, improving patient convenience without compromising safety 5.
Research on 2,297 injections of 200 mg iron sucrose as 2-minute bolus showed 97.5% proceeded uneventfully, with only 2.5% experiencing minor adverse events and no serious reactions requiring hospitalization 5.
Important Safety Considerations
- No test dose required for iron sucrose 4, 1
- Monitor for hypersensitivity reactions during and after administration, though these are rare 6
- Avoid in patients with active infection 4
- Most common adverse effect is transient metallic taste (17.9% of injections), which is mild and self-limiting 5
Monitoring After Treatment
Following iron repletion, monitor:
- Hemoglobin: Significant increase typically evident after 3 doses, persisting at least 5 weeks after final dose 7
- Transferrin saturation and ferritin: Should be checked at least every 3 months once target hemoglobin reached 2
- Iron parameters: Can be accurately assessed without interrupting weekly 100-125 mg dosing 2
Alternative High-Dose Formulations
If fewer visits are critical, consider switching to formulations that allow total dose infusion (ferric carboxymaltose 1000 mg, ferric derisomaltose 1000 mg, or low molecular weight iron dextran 1000 mg) which can deliver the entire 1200 mg deficit in 1-2 visits 8. However, iron sucrose remains the most studied preparation in children and has an excellent safety profile 9.